Gabriella Nicolini

February 1996 Degree in Biological Sciences, University of Milan

2000 Visiting Student c/o Department of Neurology, Cellular Neurobiology Laboratory, Mayo Clinic, Rochester (MN), USA

January 2001 PhD in Morphology Sciences, University of Milan

2001-2005 Post doc fellowship c/o Department of Neuroscience and Biomedical Technology, University of Milano-Bicocca

2005-2007 Research fellowship c/o Department of Neuroscience and Biomedical Technology, University of Milano-Bicocca

2007-2024 Assistant professor (Histology and Embriology) c/o School of Medicine and Surgery (former Department of Neuroscience and Biomedical Technology), University of Milano-Bicocca

2024 to present Associate professor (Histology and Embriology) c/o School of Medicine and Surgery, University of Milano-Bicocca

RESEARCH ACTIVITIES

1. Peripheral neurotoxicity induced by antineoplastic drugs (CIPN): in vivo and in vitro models.
   Antineoplastic drug targeting studies and in vitro and in vivo studies of neuroprotective agents.
   SARM1/NMNAT2 pathway involvement in CIPN.
2. Glioblastoma molecular and morphological characterization and development of new molecules against glioblastoma. 2D and 3D in vitro models.

ONGOING AND RECENT RESEARCH PROJECTS

• ESRF, European Synchrotron Radiation Facility (ESRF), Grenoble. Multiscale tomographic characterization of 3D bioprinted glioblastoma multiforme for drug screening 
• Università degli Studi di Camerino. Progetto: New copper based chemotherapic molecules for the treatment of glioblastoma
• Università degli Studi di Parma. New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma
• SPILLO project. Biological validation of the software “SPILLO potential binding sites searcher” as a tool to identify targets and off targets of drugs and small molecules
• 2023-2025 Funding: Filippo Serpero Pharmacological Institute Foundation. Project “Histone deacetylase 6 (HDAC6) inhibitors: possible neuroprotectors for chemotherapy-induced peripheral neuropathy” Role: Principal Investigator
• 2022-2024. Funding:Giovanni Celeghin Onlus Foundation against brain tumors. Project “Multidisciplinary Approach to Optimize The Promising Anti Glioblastoma Candidate MV1035”. Role: Principal Investigator

FURTHER DETAILS

please visit LinkedIn